![[Des-Arg9]-Bradykinin acetate](https://file.medchemexpress.com/product_pic/hy-p0298a.gif "Click to View [Des-Arg9]-Bradykinin acetate Product Detail")
![Sar-[D-Phe8]-des-Arg9-Bradykinin](https://file.medchemexpress.com/product_pic/hy-103291.gif "Click to View Sar-[D-Phe8]-des-Arg9-Bradykinin Product Detail")
![[Des-Arg9]-Bradykinin](https://file.medchemexpress.com/product_pic/hy-p0298.gif "Click to View [Des-Arg9]-Bradykinin Product Detail")
![Lys-[Des-Arg9]Bradykinin TFA](https://file.medchemexpress.com/product_pic/hy-103295a.gif "Click to View Lys-[Des-Arg9]Bradykinin TFA Product Detail")
![[Des-Arg10]-HOE I40 TFA](https://file.medchemexpress.com/product_pic/hy-p5518a.gif "Click to View [Des-Arg10]-HOE I40 TFA Product Detail")
![Lys-[Des-Arg9]Bradykinin](https://file.medchemexpress.com/product_pic/hy-103295.gif "Click to View Lys-[Des-Arg9]Bradykinin Product Detail")
![Des-Arg9-[Leu8]-Bradykinin acetate](https://file.medchemexpress.com/product_pic/hy-p3209.gif "Click to View Des-Arg9-[Leu8]-Bradykinin acetate Product Detail")
![[Des-Arg10]-HOE I40](https://file.medchemexpress.com/product_pic/hy-p5518.gif "Click to View [Des-Arg10]-HOE I40 Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
23 Results for "
bradykinin B1 receptor
" in MedChemExpress (MCE) Product Catalog:
Products (23)
23 Results for "bradykinin B1 receptor" in MCE Product Catalog:
2
2 Cited Publications
Target:
Research Areas:
SSR240612 is a potent, and orally active specific non-peptide bradykinin B1 receptor antagonist, with Kis of 0.48 nM and 0.73 nM for B1 kinin receptors of human fibroblast MRC5 and HEK cells expressing human B1 receptors, 481 nM and 358 nM for B2 receptors of guinea pig ileum membranes and CHO cells expressing human B1 receptor, respectively.
1
1 Cited Publications
Cat. No.: HY-P0298A
CAS No.: 23827-91-0
Target:
Research Areas:
Target:
Research Areas:
Target:
Research Areas:
ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse .
Cat. No.: HY-168906
CAS No.: 1119282-90-4
Target:
Research Areas:
BI-113823 is an orally active, blood-brain barrier-permeable bradykinin B1 receptor antagonist, with a Ki value of 5.3 nM for human receptors and 13.3 nM for rat receptors. BI-113823 reduces inflammation-induced mechanical hyperalgesia, as well as the mechanical sensitivity of peripheral afferent nerves and spinal nociceptive-specific neurons. BI-113823 alleviates liver fibrosis and portal hypertension, and improves survival in chronic liver disease models. BI-113823 inhibits the activities of monocytes, neutrophils and hepatic stellate cells, as well as the PI3K/Akt signaling pathway. BI-113823 can be used in research related to inflammatory pain, liver fibrosis and portal hypertension .
Cat. No.: HY-W704574
CAS No.: 77102-28-4
Research Areas:
Mergetpa is a reversible Arg-carboxypeptidase inhibitor with high affinity. Mergetpa reduces B1R. Mergetpa blocks the overexpression of IL-1β protein and mRNA in glucose-fed rats. Mergetpa significantly increases the expression of IL-1β protein in the renal cortex. Mergetpa is used to block the conversion of kinins and B2 receptor antagonists into metabolites lacking the C-terminal arginine. Mergetpa inhibits the time-dependent enhancement of the response of isolated rabbit aorta to bradykinin. Mergetpa preserves the chemotactic activity of full-length SDF-1α on cells. Mergetpa reverses hyperglycemia, excessive weight gain, elevated levels of oxidative stress markers and overexpression of inflammatory markers in glucose-fed rats .
Target:
Research Areas:
Cat. No.: HY-P4676
CAS No.: 71800-37-8
Target:
Research Areas:
Cat. No.: HY-P0298
CAS No.: 15958-92-6
Target:
Research Areas:
Cat. No.: HY-158262
CAS No.: 578727-81-8
Target:
Research Areas:
Bradykinin B1 receptor antagonist 1 (compound 6B) is a potent and cross the blood-brain barrier bradykinin B1 antagonist. Bradykinin B1 receptor antagonist 1 has the potential for the research of pain .
Target:
Research Areas:
Cat. No.: HY-P5518A
Target:
Research Areas:
Cat. No.: HY-103295
CAS No.: 71800-36-7
Target:
Research Areas:
Cat. No.: HY-P3209
CAS No.: 115035-45-5
Target:
Research Areas:
Cat. No.: HY-P3232
CAS No.: 180981-09-3
Target:
Research Areas:
Cat. No.: HY-P2109
CAS No.: 284037-77-0
Target:
Research Areas:
Cat. No.: HY-15042A
CAS No.: 1159193-97-1
Target:
Research Areas:
(Rac)-MK 0686 is the racemate of MK 0686. MK 0686 is a bradykinin B1 receptor antagonist .
Cat. No.: HY-P5518
CAS No.: 1054763-33-5
Target:
Research Areas:
Cat. No.: HY-100301
CAS No.: 215258-13-2
Target:
Research Areas:
FR167344 free base is an orally active, nonpeptide bradykinin receptor B2 antagonist. FR167344 free base shows a high affinity binding to the B2 receptor with an IC50 value of 65 nM and no binding affinity for the B1 receptor.
Cat. No.: HY-P1650
CAS No.: 215713-39-6
Synonyms: B 9870
Target:
Research Areas:
Breceptin (B 9870) is an antagonist of the bradykinin B1/B2 receptor (B1/B2R). Breceptin exhibits an irreversible antagonist effect on B2R, inhibiting the vasodilation induced by Bradykinin (HY-P0206) in the rabbit carotid vein contraction experiment. B-9870 shows partial agonist properties in HEK 293 cells with high expression of B2R, and can activate ERK1/2 phosphorylation, calcium ion mobilization, arachidonic acid release, and receptor internalization. Breceptin can be used in research to inhibit breast cancer and non-small cell lung cancer .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
